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Abstract 
Background: The metabolic syndrome increases mortality risk.  However, as “non-affected” individuals 
may still have up to two risk factors, the utility of using three or more components to identify the 
syndrome, and its predictive advantage over individual components have yet to be determined. 
Methods: Participants, male Vietnam-era veterans (n = 4265) from the USA, were followed-up from 
1985/86 for 14.7 years (61,498 person-years), and all-cause and cardiovascular disease deaths collated.  
Cox’s proportional-hazards regression was used to assess the effect of the metabolic syndrome and its 
components on mortality adjusting for a wide-range of potential confounders. 
Results: At baseline, 752 participants (17.9%) were identified as having metabolic syndrome.  There 
were 231 (5.5%) deaths from all-causes, with 60 from cardiovascular disease.  After adjustment for a 
range of covariates, the metabolic syndrome increased the risk of all-cause, HR 2.03, 95%CI 1.52, 2.71, 
and cardiovascular disease mortality, HR 1.92, 95%CI 1.10, 3.36.  Risk increased dose-dependently with 
increasing numbers of components.  The increased risk from possessing only one or two components was 
not statistically significant.  The adjusted risk for four or more components was greater than for only three 
components for both all-cause, HR 2.30, 95%CI 1.45, 3.66 vs. HR 1.70, 95%CI 1.11, 2.61, and 
cardiovascular disease mortality, HR 3.34, 95%CI 1.19, 9.37 vs. HR 2.81, 95%CI 1.07, 7.35.  The 
syndrome was more informative than the individual components for all-cause mortality, but could not be 
assessed for cardiovascular disease mortality due to multicollinearity.  Hyperglycaemia was the individual 
strongest parameter associated with mortality. 
Conclusions: The metabolic syndrome is informative in predicting mortality, with risk increasing as the 
number of components increase above the threshold required for diagnosis.   
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Introduction 
The metabolic syndrome, a constellation of symptoms encompassing central obesity, hypertension, 
hyperglycaemia, hypertriglyceridaemia, and low HDL-cholesterol, has been associated with increased all-
cause and cardiovascular disease mortality in a number of populations.1-14  Most studies have focussed on 
whether the presence of the metabolic syndrome increases all-cause or cardiovascular disease mortality 
and often do not appear to exclude existing cardiovascular disease,15 a major determinant of subsequent 
events.16  Additionally, the utility of using three or more components to identify the condition, given that 
a significant proportion of the non-affected population may have up to two risk factors, has yet to be 
determined, as has the advantage of using the metabolic syndrome over its individual components.  
Similarly, the question arises whether those with the condition but with more than the three components 
required are at greater risk than those who just meet the threshold for diagnosis.  In this study we use the 
well-characterised Vietnam Experience Study to address these issues in a sample of male veterans. 
 
Methods 
Participants and procedure 
Details of sampling at each stage of data collection performed in 1985/86 are shown in Figure 1.  
Inclusion criteria were: entered military service for the United States of America between January 1, 1965 
and December 31, 1971; served only one term of enlistment; served at least 16 weeks of active duty; 
earned a military specialty other than “trainee” or “duty soldier”; had a military pay grade at discharge no 
higher than sergeant.  Information on place of service and ethnicity was extracted from the military 
archives.  From the subsequent telephone survey, socio-economic position was measured using household 
income in midlife and the grade from which participants left school.  Frequency of alcohol consumption 
was classified as number of units per week.  Smoking habits and marital status were ascertained using 
standard questions.  Participants were asked whether they had a range of physician-diagnosed diseases 
including hypertension, cancer, coronary heart disease (CHD), and diabetes.17,18   
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 From a fasted blood sample, triglycerides and cholesterol fractions were assessed using a Kodak 
Ektachem 700 autoanalyzer.17,18  Serum glucose level was determined with an adaptation of the glucose 
oxidase-peroxidase-chromogen-coupled system.17,18  Blood pressure was measured twice in the right arm 
using a sphygmomanometer and an average computed.  Height and weight were measured to calculate 
body mass index (BMI, kg/m2).   
 Subsequent to completion of the medical examination, attempts were made to match study 
participants against mortality databases over a 15 year period.  Mean age at medical examination was 
38.3 yr. (range: 31.1 to 49.0).  The censor date for the study was taken to be at medical examination or 
death or 31 December 2000, whichever occurred first.  The effective sample size was 4256.  Ethical 
approval for the study was given by various bodies, including the US Centers for Disease Control.17,18   
 
Definition of the metabolic syndrome 
The metabolic syndrome and its components were defined using the American Heart 
Association/National Heart, Lung, and Blood Institute scientific statement.19, which made slight 
modifications to the Adult Treatment Panel III recommended diagnostic criteria.20  According to this 
definition,  participants were classified as having the metabolic syndrome if any three of the following 
were present: BMI >30 kg/m2 (in the absence of data on waist circumference, BMI at this threshold is 
regarded by the World Health Organisation as an acceptable substitute in defining the metabolic 
syndrome;21) fasting plasma glucose ≥5.6 mmol/l (100 mg/dl) and/or receiving medication for diabetes; 
triglycerides ≥1.7 mmol/l (150 mg/dl); HDL-cholesterol level <1.036 mmol/l (40 mg/dl); and blood 
pressure ≥130/85 mm Hg and/or use of antihypertensive medication.   
 
Statistical analysis  
Data from normally distributed parameters are presented as mean ± SD, whereas skewed data were 
logarithmically transformed and expressed as geometric mean with 95% confidence intervals (95%CIs).  
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Demographic, health behaviour, service-related, metabolic, and haemodynamic variables were compared 
between those with and without metabolic syndrome using chi-square and Students t-test.  Multivariable 
Cox’s proportional-hazards regression was used to assess the effect of the metabolic syndrome and its 
components on all-cause and cardiovascular disease mortality.  Potential confounders included were: age 
(years), ethnicity (white, black, other (Hispanics, Asians, Pacific Islanders, Native American or, Alaskan), 
alcohol consumption (units per week), smoking (never, ex-, current), total cholesterol (mmol/l), education 
(grades: ≤11, 12, ≥12), marital status (single, married, other), place of service (Vietnam, other overseas, 
USA), income during midlife (US$≤20,000, 20,001-40,000, >40,000 per year).  The parameters were 
added in a hierarchical manner as described in tables 2 and 3.  These covariates were chosen a priori as 
they have all been associated with health outcomes in this dataset.22,23 and others (e.g.,24)  SPSS (version 
15.0 for windows, Chicago, IL, USA) was used in the analyses. 
 
Results 
Of the 4,256 men with complete data, 56 were excluded due to a history of existing cardiovascular 
disease, leaving 4,200 who were included in these analyses.  The participants were followed-up for a 
mean duration of 14.7 years, resulting in 61,498 person-years of data.  There were a total of 231 (5.5%) 
deaths from any cause, with 60 resulting from cardiovascular disease ((ICD-9: 390–434,436–448, ICD-
10: I00–I78); 67% of which were associated with ischaemic heart disease (ICD-9: 410–414,429.2, ICD-
10: I20–I25)).  At baseline, 752 participants (17.9%) had metabolic syndrome.  As expected those with 
the metabolic syndrome had increased levels of the components of the syndrome (Table 1).  The 
prevalence of lifestyle factors, smoking and alcohol consumption, were similar between the groups.  
Those with the metabolic syndrome generally had lower levels of education.   
 In Cox proportional hazards regression, having the metabolic syndrome was associated with a 
doubling of risk of both all-cause and cardiovascular disease mortality (Table 2).  After adjustment for 
potential confounders (age, alcohol consumption, smoking, total cholesterol, education, ethnicity, marital 
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status, place of service, income during midlife), the risk effect sizes were generally undiminished.  
Compared to those without any components of the metabolic syndrome those with the condition had three 
times the risk of cardiovascular mortality.   
 Of the five individual components, hyperglycaemia, obesity, and low HDL-cholesterol levels were 
all associated with increased all-cause mortality.  As in the analyses of metabolic syndrome, adjustment 
for potential confounding factors had a minimal effect on the risk estimates.  However, when the 
components were mutually adjusted, only hyperglycaemia and obesity remained independent 
determinants of all-cause mortality, increasing risk by 58% and 57%, respectively.  Of the individual 
components, hyperglycaemia was most strongly associated with cardiovascular disease mortality with a 
126% excess risk, and 109% when adjusted for the other metabolic syndrome components.  However, for 
the remaining individual components the relatively small number of deaths from cardiovascular disease 
meant that despite excess risks of about 60% or more none reached significance in the fully adjusted 
model.  The adjustment for total blood cholesterol attenuated the risk effect estimates, particularly for 
triglycerides.  Mutual adjustment reduced the strength of the associations for the metabolic syndrome 
components.  High blood pressure, as defined by using blood pressure ≥130/85 mm Hg and/or use of 
antihypertensive medication, showed no evidence of an association with cardiovascular mortality.  In part 
this may be due to the close relationship between ethnic background and hypertension.  The black 
participants had significantly more hypertension (64.0%) when compared to the whites (48.7%) or those 
of other origin (53.0%, p<0.001).   
 A total of 2308 (55.0%) had one or two components of the metabolic syndrome.  For 
cardiovascular mortality, there was a clear dose-dependent increase in the hazard ratios with an increasing 
number of components (Table 2, Figure 2), with the presence of a single component non-significantly 
increasing risk by 71% 95%CI -29, 309%.  Only the presence of three (or more) components was 
associated with significantly increased risk of death, p = 0.036.  The risk associated with four or more 
components was significantly greater than that associated with only three components for both all-cause, 
Thomas, N., Phillips, A.C., Carroll., D., Gale, C.R., & Batty, G.D., & et al., (2010).  The metabolic 
syndrome adds utility to the prediction of mortality over its components: the Vietnam Experience 
Study.  Atherosclerosis, 210, 256-261. http://dx.doi.org/10.1016/j.atherosclerosis.2009.10.045 
 
7
HR 2.30, 95%CI 1.45, 3.66, vs. HR 1.70, 95%CI 1.11, 2.61, and cardiovascular disease mortality, HR 
3.34, 95%CI 1.19, 9.37, vs. HR 2.81, 95%CI 1.07, 7.35).  The overall p for trend in this analysis (p = 
0.083) did not quite reach significance.  However, if those with existing cardiovascular disease were 
included in the analysis the trend was statistically significant (p = 0.035).  When the grouping was none; 
one or two; and three or more components there was a clear significant dose-dependent effect for both all-
cause and cardiovascular disease mortality (Table 2).  For all-cause mortality, risk only appeared to 
increase in those with three or more components (Table 2, Figure 2).  To assess whether the composite 
variable, metabolic syndrome, provided additional predictive information over the individual components, 
metabolic syndrome was also added to the analyses.  For all-cause mortality, only the metabolic 
syndrome variable remained significant, increasing risk by 81%, 95%CI 6, 11%, p = 0.031.  However, in 
parallel analyses for cardiovascular disease mortality, the model appeared to be invalid as 
multicollinearity was identified, and the associations are thus not shown.  Accordingly, this model may 
not afford an appropriate test in this instance, and thus the associations are not shown. 
 A number of other parameters that have been shown in earlier studies to contribute to mortality 
were also identified as significant predictors of mortality in the current study.  For instance current 
smoking increased mortality by 65%, 95%CI 16, 136%, p = 0.005.  Using alcohol consumption as a 
continuous variable, there was a significant increase in all-cause mortality of 0.7%, 95%CI 0.2, 1.1% per 
unit of alcohol per week, p=0.005.  However, this was largely the result of those consuming 21 units per 
week or more where the risk increased by 51%, 95%CI 3, 112%, p = 0.035 when compared to those not 
consuming alcohol.  Being divorced/separated/widowed, HR 2.00, 95%CI 1.35, 2.97, p = 0.001, 
significantly increased the risk of all-cause mortality relative to those that had remained single.  Having 
black ancestry or being Hispanic, Asian, a Pacific Islander, Native American or Alaskan increased the 
risk of all-cause mortality by 80%, 95%CI 25, 160, p = 0.001, and 77%, 95%CI 12, 179%, p = 0.014, 
respectively.  Likewise, the indicators of higher socioeconomic status were associated with a reduction in 
risk.  For instance, those earning more than US$40,000 had a 57% reduction in risk, 95%CI 28, 74%, p = 
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0.001 compared to those earning less than US$20,000.  There was also a significant trend for increasing 
education to be associated with reduced mortality, p = 0.020, although the individual categories failed to 
reach significance, eg those with the highest education level had 28% 95%CI -10, 54% reduction in risk, 
p = 0.129.  Total cholesterol was a clear determinant of cardiovascular disease mortality increasing the 
risk 48% per mmol/l, 95%CI 23, 78%, p < 0.001 in the mutually adjusted analyses.   
 
Discussion 
The present analyses of data from middle-aged male veterans indicate that the metabolic syndrome 
doubles the risk of both all-cause and cardiovascular disease mortality.  As such, our results are consistent 
with the vast bulk of previous studies.1-14  The main outcomes were not attenuated following adjustment 
for a wide-range of potential confounders.  The metabolic syndrome proved to be a stronger predictor of 
all-cause mortality than its individual components, a result for which there is precedent.25  The predictive 
value of the metabolic syndrome was similar whether the other components were included in the hazard 
model or not, suggesting that in our analysis multicollinearity was not a major issue.  This contrasted with 
the analysis of determinants of cardiovascular mortality.  Examination of the model containing the 
metabolic syndrome and its components, suggested that the hyperglycaemic component was the most 
informative, and that the metabolic syndrome was non-significantly associated with reduced risk, a result 
that is almost certainly artefactual.  It is therefore important in studies assessing the utility of the 
syndrome in predicting risk relative to its components to consider the issue of multicollinearity. 
 The extent of the risk faced by those without the metabolic syndrome but carrying component risk 
factors remains unclear.  In the current study, as the number of metabolic syndrome components 
increased there was a clear dose-dependent increase in risk of all-cause and cardiovascular mortality, 
including for those with the metabolic syndrome where having 4 or 5 components was associated with 
greater risk than having only 3 components.  The increase in risk was particularly evident for 
cardiovascular mortality, whereby the presence of even one component increased risk by 71%, although 
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confidence intervals around this estimate were wide.  Given that 55% of the current population had one or 
two components this could constitute a large potentially undertreated group if treatment were only 
initiated if based solely on the presence of the metabolic syndrome.  A larger study with about 1500 
deaths also found incremental risk commencing from one risk factor for cardiovascular disease mortality 
and two components for all-cause mortality consistent with our findings.2  These data show a continuum 
of risk, as seen with the individual components, rather than there being a threshold effect occurring at the 
level used to define the metabolic syndrome.   
 Hypertension showed no evidence of a relationship with either all-cause or cardiovascular disease 
mortality.2  In part this may be due to the close relationship between ethnic background and hypertension.  
The black participants had significantly more hypertension when compared to the whites or those of other 
origin (15 and 11% more, respectively).  Therefore in the analyses, adjusting for ethnicity may have 
removed some of the variance that would have otherwise been attributed to the hypertension risk factor.  
However, even in the crude analyses in the increased hazard ratios did not reach significance, suggesting 
other parameters may be masking the association.  Hypertension has been shown to be associated with 
cardiovascular disease mortality in some,1-3 but not all studies.13,26 
 The relationship between hyperglycaemia and mortality is more heterogeneous.  Although many 
studies do not report the associations of the individual components, some reported similar observations to 
those in the current study with hyperglycaemia being strongly associated with cardiovascular 
disease1,3,8,13 and all-cause mortality,3,8 with a similar strength of relationship to that exhibited by the 
metabolic syndrome in these studies.  However, in other studies hyperglycaemia was not an independent 
predictor of mortality.2,26  Although some of the variation is likely the result of differing definitions and 
population structures, duration may also be an issue with those studies finding a stronger effect of 
glucose, including the current study, tending to have follow-up periods of more than a decade,3,8,13 
contrasting those that did not identify an association.26 
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 One limitation of the current study is the lack of availability of waist circumference measures.  
However, a number of studies have replaced the central obesity criterion for the metabolic syndrome with 
the BMI threshold for obesity; this is also regarded by the WHO as an acceptable substitute in defining 
the metabolic syndrome.21  Another limitation is that in some of the subgroup analyses, the numbers of 
deaths are small which results in larger confidence intervals.  This means that hazard ratios of a similar 
magnitude to others that are statistically significant do not reach conventional levels of significance.  
However, this is not an issue with the primary study outcomes, and was large enough to allow for the 
assessment of the level of risk of increasing numbers of components of the syndrome.  The study was 
very well characterised which enabled the adjustment of a wide range of potential confounders. 
 In summary, as the number of metabolic syndrome components increased so did the risk of 
mortality and even in those defined as having the syndrome those with four components or more were at 
increased risk of dying relative to those with only three components.  The metabolic syndrome was a 
better predictor of all-cause mortality than its components suggesting additional utility of the parameters 
in identifying those at greater risk.  These important factors have been rarely reported in studies assessing 
the impact of the syndrome on mortality.  Overall, the metabolic syndrome at least doubled the likelihood 
of all-cause and cardiovascular disease mortality after removal of the effects of potential confounding 
factors and is clearly a useful measure of identifying those at elevated risk of dying in this population. 
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Table 1 Baseline anthropometric, blood pressure and plasma biochemical characteristics in the 
participants. 
Parameters  Metabolic syndrome (n=4200) p value 
 Without (n=3448) With (n=752)  
Age (years) 38.3±2.5 38.7±2.5 <0.001 
Systolic blood pressure (mm Hg) 121±11 131±12 <0.001 
Diastolic blood pressure (mm Hg) 83±9 91±9 <0.001 
Body mass index (kg/m2) 25.0±3.0 30.0±4.2 <0.001 
Body weight (kg) 79.6±11.3 95.4±15.3 <0.001 
Total cholesterol (mmol/l) 5.4±1.1 5.8±1.1 <0.001 
HDL-cholesterol (mmol/l) 1.21±0.32 0.90±0.20 <0.001 
Triglyceride (mmol/l) 0.91 (0.89, 0.92) 2.05 (1.97, 2.14) <0.001 
Fasting glucose (FPG, mmol/l) 5.1±0.7 5.8±1.6 <0.001 
Tobacco consumption (units/wk) 6.69 (6.38, 7.00) 6.75 (6.03, 7.57) 0.868 
Alcohol consumption (%) 
     Former / Current 
 
28.2 / 46.2 
 
29.2 / 45.7 
 
0.850 
Black ethnicity / other* (%) 12.1 / 5.9 9.6 / 8.5 0.005 
Education: 12 / ≥13grade (%) 36.6 / 52.1 37.3 / 47.1 0.001 
Marital status (%) 
     Divorced, separated, widowed / Married
 
19.2 / 72.3 
 
12.8 / 79.2 
 
0.003 
Income: 20,001-40,000 / ≥40,001 (%) 50.2 / 22.0 49.2 / 20.6 0.349 
Service in Vietnam / Other overseas (%) 54.7 / 25.8 57.4 /25.2 0.292 
Mortality: all-cause/CHD (%) 4.7 / 1.0 9.2 / 2.7 <0.001 / <0.001 
Thomas, N., Phillips, A.C., Carroll., D., Gale, C.R., & Batty, G.D., & et al., (2010).  The metabolic 
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Normal data, Mean±SD; Skewed data, Geometric mean (geometric 95 % confidence intervals of the 
mean); categorical data, percentages; *Comprises Hispanics, Asians, Pacific Islanders, American Indians, 
and Alaskan Natives 
Thomas, N., Phillips, A.C., Carroll., D., Gale, C.R., & Batty, G.D., & et al., (2010).  The metabolic syndrome adds utility to the prediction of 
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Table 2: Adjusted hazard ratios (CIs) for all-cause and cardiovascular disease mortality associated with the metabolic syndrome (MES) 
 All-cause mortality Cardiovascular disease mortality 
Adjustments Deaths/ 
N 
Crude Age,  Age, SES, 
demographics/ 
lifestyle 
Deaths/ 
N 
Crude Age Age, SES, 
demographics/ 
lifestyle 
Metabolic syndrome        
    No components 51/1140 1 (ref) 1 (ref) 1 7/1140 1 1 1 
    1-2 components 111/2308 1.11 (0.80, 1.54) 1.10 (0.79, 1.53) 0.95 (0.68, 1.33) 34/2308 2.48* (1.10, 5.58) 2.40* (1.06, 5.40) 1.87 (0.82, 4.26) 
    ≥3 components 69/752 2.12* (1.48, 3.03) 2.08* (1.45, 2.98) 1.96* (1.35, 2.85) 19/752 4.58* (1.95, 10.8) 4.29* (1.82, 10.1) 3.14* (1.30, 7.60) 
    p for trend  <0.001 <0.001 <0.001  <0.001 0.003 0.03 
Metabolic syndrome        
    0-2 components  1 1 1  1 1 1 
    ≥3 components  1.97* (1.50, 2.61) 1.95* (1.48, 2.58) 2.03* (1.52, 2.71)  2.30* (1.36, 3.89) 2.20* (1.30, 3.72) 1.92* (1.10, 3.36) 
p value *<0.05.  Adjusted for age, demographics/lifestyle (ethnicity, alcohol consumption, smoking, total cholesterol), and socioeconomic status 
(SES; education, marital status, place of service, income during midlife).  
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Table 3: Adjusted hazard ratios for all-cause and cardiovascular disease mortality associated with the metabolic syndrome components 
Components All-cause mortality Cardiovascular disease mortality 
Adjustments Crude Age Age, SES, 
demographics  
Crude Age Age, SES, 
demographics  
Hypertension 1.21 (0.94, 1.56) 1.20 (0.93, 1.09) 1.13 (0.87, 1.48) 1.29 (0.78, 2.13) 1.26 (0.76, 2.07) 1.06 (0.63, 1.77) 
High fasting glucose 1.91* (1.43, 2.54) 1.88* (1.41, 2.50) 1.76* (1.30, 2.37) 2.89* (1.73, 4.82) 2.72* (1.63, 4.57) 2.26* (1.31, 3.91) 
High triglycerides  1.41 (1.01, 1.89) 1.38 (1.03, 1.86) 1.34 (0.94, 1.80) 2.49* (1.49, 4.15) 2.37* (1.42, 3.96) 1.66 (0.95, 2.90) 
Low HDL-cholesterol 1.31* (1.01, 1.69) 1.31* (1.01, 1.69) 1.35* (1.04, 1.77) 1.53 (0.93, 2.51) 1.52 (0.93, 2.50) 1.61 (0.95, 2.73) 
Obesity 1.79* (1.31, 2.45) 1.77* (1.29, 2.43) 1.86* (1.34, 2.57) 1.78 (0.97, 3.07) 1.72 (0.93, 3.17) 1.65 (0.86, 3.14) 
Mutually-adjusted        
Hypertension 1.00 (0.76, 1.31) 1.00 (0.76, 1.31) 0.95 (0.72, 1.24) 0.95 (0.56, 1.62) 0.95 (0.56, 1.61) 0.91 (0.53, 1.55) 
High fasting glucose 1.72* (1.27, 2.32) 1.70* (1.26, 2.30) 1.58* (1.16, 2.14) 2.47* (1.43, 4.24) 2.34* (1.37, 4.07) 2.09* (1.20, 3.64) 
High triglycerides  1.11 (0.80, 1.54) 1.09 (0.79, 1.52) 1.10 (0.79, 1.53) 1.94* (1.09, 3.47) 1.87* (1.04, 3.34) 1.41 (0.78, 2.55) 
Low HDL-cholesterol 1.16 (0.88, 1.53) 1.16 (0.88, 1.54) 1.14 (0.86, 1.52) 1.14 (0.66, 1.97) 1.16 (0.67, 1.99) 1.28 (0.73, 2.24) 
Obesity 1.48* (1.05, 2.08) 1.47* (1.05, 2.08) 1.57* (1.11, 2.22) 1.16 (0.60, 2.25) 1.15 (0.59, 2.23) 1.28 (0.65, 2.50) 
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p value *<0.05.  Adjusted for age, demographics/lifestyle (ethnicity, alcohol consumption, smoking, total cholesterol), and socioeconomic status 
(SES; education, marital status, place of service, income during midlife).   
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Figure 1: Sampling in the Vietnam Experience Study 
 
Figure 2: Increasing hazard ratios for all-cause (p for trend<0.001) and 
cardiovascular disease (p for trend=0.083) mortality with increasing components of 
the metabolic syndrome 
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